Amintax vaginal suppositories 35000 + 35000 + 100000ME, No. 10

Treatment of infectious and inflammatory diseases caused by sensitive microorganisms:

fungal, nonspecific and mixed vaginitis, cervicovaginitis and vulvovaginitis;

Preoperative prevention of infectious complications during gynecological interventions:

intrauterine diagnostic procedures,

diathermocoagulation of the cervix,

childbirth.

Amintax suppositories are intended for intravaginal use.

Suppositories should be administered in 1 pc. deep into the vagina, lying on your back, before going to bed.

The duration of the treatment course is 12 days, the prophylactic course is 6 days.

If you miss the next appointment, you do not need to double the dose, you must continue treatment as usual.

active ingredients:

nystatin - 100,000 ME (International Units),

neomycin - 35,000 ME,

polymyxin B - 35,000 ME;

Excipients:

macrogol 400 and macrogol 1500 (in a ratio of 5:95) - until a suppository weighing 2400 mg is obtained.

Absolute: I trimester of pregnancy; lactation; hypersensitivity to any component of Amintax.

With caution, if the benefit to the mother from the forthcoming treatment outweighs the potential risk to the fetus, the drug is prescribed in the II and III trimesters of pregnancy.

Amintax is a combined antibacterial drug for use in gynecology.

Release form and composition

Dosage form - vaginal suppositories: torpedo-shaped, yellow, possibly the presence of a funnel-shaped depression and / or an air rod (5 pcs. In cell contour packs, 2 packs in a cardboard box together with instructions for the use of Amintax).

Composition of 1 suppository:

active ingredients:

nystatin - 100,000 ME (International Units),

neomycin - 35,000 ME,

polymyxin B - 35,000 ME;

Excipients:

macrogol 400 and macrogol 1500 (in a ratio of 5:95) - until a suppository weighing 2400 mg is obtained.

Pharmacological properties:

Pharmacodynamics:

Amintax is a combined preparation, the effect of which is due to the properties of active substances: nystatin is an antifungal agent, an antibiotic of the polyene group, which has a fungicidal effect on pathogenic fungi, especially yeast-like genus Candida albicans, Histoplasma and Cryptococcus; neomycin and polymyxin B are antibiotics (aminoglycoside and polypeptide, respectively) that are active against many gram-positive (including corynebacteria and Staphylococcus aureus) and gram-negative (Escherichia coli, Enterobacter aerogenes, Enterococcus faecium, Klebsiella pneumgarisium, Protein influenzae, Ureaplasma urealyticum) microorganisms.

The drug also improves trophic processes in the vaginal mucosa.

Anaerobic bacteria and Streptococcus spp. Are insensitive to the action of Amintax.

Pharmacokinetics:

With intravaginal use of the drug, the active substances are quickly distributed over the vaginal mucosa, practically not absorbed, and have a local bactericidal and fungicidal effect. Indications for use:

Treatment of infectious and inflammatory diseases caused by sensitive microorganisms:

fungal, nonspecific and mixed vaginitis, cervicovaginitis and vulvovaginitis;

Preoperative prevention of infectious complications during gynecological interventions:

intrauterine diagnostic procedures,

diathermocoagulation of the cervix,

childbirth.

Contraindications:

Absolute: I trimester of pregnancy; lactation; hypersensitivity to any component of Amintax.

With caution, if the benefit to the mother from the forthcoming treatment outweighs the potential risk to the fetus, the drug is prescribed in the II and III trimesters of pregnancy.

Amintax, instructions for use:

Method and dosage:

Amintax suppositories are intended for intravaginal use.

Suppositories should be administered in 1 pc. deep into the vagina, lying on your back, before going to bed.

The duration of the treatment course is 12 days, the prophylactic course is 6 days.

If you miss the next appointment, you do not need to double the dose, you must continue treatment as usual.

Side effects:

Local reactions: itching, burning, irritation in the vagina; allergic reactions, including allergic contact eczema.

In the case of long-term treatment, there is a possibility of systemic side effects inherent in neomycin.

Overdose

Given the local method of application of Amintax, an overdose is unlikely.

If the suppository is accidentally taken orally, the likelihood of developing systemic effects (nephro- and ototoxicity) is not excluded.

With continued treatment, the risk of allergic contact eczema increases. Therapy for the developed disorders is symptomatic.

Special instructions:

Amintax is prescribed after taking a smear and conducting a bacteriological analysis.

If after the end of the course of therapy there is no improvement, the existing symptoms worsen or new ones appear, you should immediately consult a doctor.

If clinical signs of infection persist, a repeated microbiological study is indicated to confirm the diagnosis.

The recommended duration of treatment should not be exceeded in order to prevent the formation of resistance of individual pathogens and to avoid the risk of reinfection.

It is not required to interrupt the course during menstruation, however, it is necessary to refrain from using vaginal tampons.

In case of local intolerance to Amintax, the development of allergic or other adverse reactions, you should stop using the drug and consult a doctor.

During the treatment period, it is recommended to refrain from sexual intercourse.

Latex products (including diaphragms) should not be used as there is a risk of rupture.

Influence on the ability to drive vehicles and complex mechanisms

The components included in Amintax do not affect the speed of psychomotor reactions and the ability to concentrate.

Application during pregnancy and lactation

In the first trimester of pregnancy, the use of vaginal suppositories Amintax is contraindicated.

In the II and III trimesters, the drug can be prescribed only after a thorough assessment of the expected benefits and possible risks.

During lactation, drug treatment is contraindicated.

In cases of absolute need for a course of therapy, women are advised to stop breastfeeding.

Childhood use

Information not provided by the manufacturer.

With impaired renal function

Patients with renal insufficiency should consult a doctor before starting treatment.

For violations of liver function

There is no information indicating the need to change the dosage regimen of Amintax in case of functional impairment of the liver.

Drug interactions:

You should not use spermicides during the treatment period, since they can reduce the effectiveness of the drug.

The drug interaction of Amintax with other drugs has not been studied.

Terms and conditions of storage:

Store at a temperature not exceeding 25 ? C, out of the reach of children.

Shelf life is 2 years.

Conditions of dispensing from pharmacies

Dispensed by prescription.